Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02369159 · ClinicalTrials.gov registry record · Phase 3
Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza
A Phase 3 study of Influenza, sponsored by BioCryst Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 137
- Enrollment target
- 10
- Study locations
NCT02369159 is a Phase 3 study of Influenza that has completed, run by BioCryst Pharmaceuticals. The registered enrollment target is 137 participants, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 10 study locations across 6 states.
The verdict
NCT02369159, a Phase 3 study of Influenza, has completed, sponsored by BioCryst Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 137 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of pediatric subjects with acute uncomplicated influenza.
Conditions Studied
Interventions
- DRUG Oseltamivir
- DRUG Peramivir
Study Locations (10)
Texas
- Peramivir Investigative Site - Houston
- Peramivir investigative site - San Antonio
- Peramivir investigative site - Splendora
Utah
- Peramivir investigative site - Draper
- Peramivir investigative site - Salt Lake City
- Peramivir investigative site - South Jordan
Louisiana
- Peramivir Investigative Site - Shreveport
Ohio
- Peramivir investigative site - Dayton
Pennsylvania
- Peramivir investigative site - Smithfield
Other
- Peramivir Investigative Site - Pretoria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2015-03-11 |
| Est. Completion | 2020-05-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02369159
The ClinicalTrials.gov registry entry for NCT02369159 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The listed sponsor is BioCryst Pharmaceuticals, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which Oseltamivir is the first listed.
NCT02369159 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Texas, Utah, Louisiana.
Frequently Asked Questions
What is clinical trial NCT02369159 about?
NCT02369159 is a clinical study titled "Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza". This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of pediatric subjects with acute uncomplicated influenza.
What is the current status of trial NCT02369159?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 137 participants. The study started on 2015-03-11. Estimated completion is 2020-05-14.
What conditions does trial NCT02369159 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT02369159?
The interventions under investigation include: Oseltamivir (DRUG), Peramivir (DRUG).
Who is sponsoring clinical trial NCT02369159?
This trial is sponsored by BioCryst Pharmaceuticals, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02369159 being conducted?
This trial has 10 study locations across Louisiana, Ohio, Pennsylvania, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
RECRUITING · Phase 3
-
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
ACTIVE NOT RECRUITING · Phase 3
-
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
COMPLETED · Phase 3
-
Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age
COMPLETED · Phase 3
-
Study of Quadrivalent Influenza Vaccine Among Children
COMPLETED · Phase 3
-
Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.